Skip to main content

Table 1 Characteristics of the strains isolated from patients infected by nontyphoidal S. enterica

From: “Does the Salmonella Genomic Island 1 (SGI1) confer invasiveness properties to human isolates?”

Serovars

SGI1-positive n (%)

SGI1-negative n (%)

S. Typhimurium (n = 36)

7 (19.4)

29 (80.6)

 DT104 (n = 9)

5 (55.6)

4 (44.4)

 Non DT104 (n = 27)

2 (7.4)

25 (92.6)

Non S. Typhimurium serovars (n = 64)

5 (7.8)

59 (92.2)

S. 4, [5], 12: i- (n = 19)

0

19 (100)

S. Enteritidis (n = 14)

0

14 (100)

S. Paratyphi B var. Java (n = 2)

0

2 (100)

S. Dublin (n = 5)

0

5 (100)

 Other serovarsa (n = 24)

5b (20.8)

19 (79.2)

Phenotypesc

SGI1-positive n (%)

SGI1-negative n (%)

Pansusceptible (n = 21)

0 (0)

21 (100)

Resistant ≥1 (n = 79)

12 (15.2)

67 (84.8)

Including penta-resistant (ACSSuT)d (n = 9)

6 (67)

3 (33)

  1. aOther serovars (n = 24): S. Ahmadi (n = 1). S. Braenderup (n = 1). S. Chester (n = 2). S. Eastbourne (n = 1). S. Eboko (n = 1). S. Hadar (n = 1). S. Hessarek (n = 2); S. Infantis (n = 2); S. Kedougou (n = 1); S. Kentucky (n = 2); S. Napoli (n = 1); S. Panama (n = 1); S. Rissen (n = 1); S. Schwarzengrund (n = 2); S. Singapore (n = 1); S. St Paul (n = 3); and a new variant: 6, 7, − (n = 1)
  2. bOther serovars with SGI1 (n = 5): S. Infantis (n = 1), S. Kentucky (n = 2), S. St Paul (n = 2)
  3. cPhenotype was determined by testing amoxicillin, amoxicillin – clavulanic acid, ceftriaxone, nalidixic acid, chloramphenicol, kanamycin, spectinomycin, streptomycin, sulphonamides, trimethoprim and doxycycline in accordance to the antibiomicrobial guidelines of CASFM- EUCAST
  4. dACSSuT: Amoxicillin, Chloramphenicol, Streptomycin, Sulphonamides and Tetracyclines